455 related articles for article (PubMed ID: 15340259)
1. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
Jass JR
Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
[TBL] [Abstract][Full Text] [Related]
2. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
[TBL] [Abstract][Full Text] [Related]
4. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
5. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
6. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.
Shia J; Ellis NA; Paty PB; Nash GM; Qin J; Offit K; Zhang XM; Markowitz AJ; Nafa K; Guillem JG; Wong WD; Gerald WL; Klimstra DS
Am J Surg Pathol; 2003 Nov; 27(11):1407-17. PubMed ID: 14576473
[TBL] [Abstract][Full Text] [Related]
7. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
10. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
11. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers.
Wheeler JM; Loukola A; Aaltonen LA; Mortensen NJ; Bodmer WF
J Med Genet; 2000 Aug; 37(8):588-92. PubMed ID: 10922385
[TBL] [Abstract][Full Text] [Related]
12. Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
[TBL] [Abstract][Full Text] [Related]
14. Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability.
Yamamoto H; Min Y; Itoh F; Imsumran A; Horiuchi S; Yoshida M; Iku S; Fukushima H; Imai K
Genes Chromosomes Cancer; 2002 Mar; 33(3):322-5. PubMed ID: 11807990
[TBL] [Abstract][Full Text] [Related]
15. Two types of sporadic multiple colorectal cancers with and without HNPCC-like genetic instability.
Komura K; Masuda H; Esumi M
Hepatogastroenterology; 1999; 46(30):3115-20. PubMed ID: 10626171
[TBL] [Abstract][Full Text] [Related]
16. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
18. [A new quantitative DNA-methylation analysis of MSI colorectal cancers helps to separate sporadic colorectal cancers from HNPCC-candidates].
Bettstetter M; Rümmele P; Hofstädter F; Dietmaier W
Verh Dtsch Ges Pathol; 2006; 90():236-43. PubMed ID: 17867602
[TBL] [Abstract][Full Text] [Related]
19. Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population.
Rovella V; Carrara S; Crucitti SC; Coco C; Magistrelli P; Lucci-Cordisco E; Anti M; Neri G; Genuardi M
Ann Oncol; 2001 Jun; 12(6):813-8. PubMed ID: 11484957
[TBL] [Abstract][Full Text] [Related]
20. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P
Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
